About Rising Biosciences Inc.
Rising Biosciences Inc. is a Pharmaceuticals company, headquartered in Sheridan, with 11 - 50 employees and annual revenue of $5M - $20M.
Rising BioSciences (OTC: RBII) is a research and development company focused on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry. Rising Biosciences is also a physicians practice management company actively developing alternative medicine ...
Seamless Pro Tip
Use this information to figure out if this company is an ideal customer for you.
Rising Biosciences Inc. Company Highlights
Phone Number
(888) 272-xxxx
Corporate Office Address
30 North Gould Street
Sheridan, 82801
Website
Rising Biosciences Inc.'s Tech Stack
Frequently Asked Questions About
Rising Biosciences Inc.
Log in or sign up to get full contact details and additional support.
What technologies does Rising Biosciences Inc. use?
Rising Biosciences Inc. uses technologies including Google Cloud, Lodash, and Polyfill.
How do I contact Rising Biosciences Inc.?
To contact Rising Biosciences Inc., visit risingbiosciences.org.
What companies are similar to Rising Biosciences Inc.?
Companies similar to Rising Biosciences Inc. include Madrigal Pharmaceuticals, Industry Pharmacists Organization, and 4C Pharma Solutions.
Where is Rising Biosciences Inc. headquartered?
Rising Biosciences Inc. is headquartered at 30 North Gould Street, Sheridan.
What is the main phone number for Rising Biosciences Inc.?
The main phone number for Rising Biosciences Inc. is (888) 272-xxxx.
What is the official website for Rising Biosciences Inc.?
The official website for Rising Biosciences Inc. is risingbiosciences.org.
What is the annual revenue of Rising Biosciences Inc.?
The annual revenue of Rising Biosciences Inc. is $5M - $20M.
How many employees does Rising Biosciences Inc. have?
Rising Biosciences Inc. has 11 - 50 employees.
What industry is Rising Biosciences Inc. in?
Rising Biosciences Inc. is in the Pharmaceuticals industry.
Last updated: October 10, 2024